Superior Prevention of Acute Rejection by Tacrolimus vs. Cyclosporine in Heart Transplant Recipients—A Large European Trial

This publication has 30 references indexed in Scilit:

• Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?
  Current Opinion in Cardiology, 2005
• Comparison of Low and High Initial Tacrolimus Dosing in Primary Heart Transplant Recipients: A Prospective European Multicenter Study
  Transplantation, 2005
• Corticosteroid-Free Immunosuppression With Tacrolimus Following Induction With Daclizumab: a Large Randomized Clinical Study
  Liver Transplantation, 2004
• An update on the efficacy of newer immunosuppressive regimens in cardiac transplantation
  Current Opinion in Organ Transplantation, 2004
• Effects of Cardiopulmonary Resuscitation on Predictors of Ventricular Fibrillation Defibrillation Success During Out-of-Hospital Cardiac Arrest
  Circulation, 2004
• Does acute cellular rejection correlate with cardiac allograft vasculopathy?
  The Journal of Heart and Lung Transplantation, 2004
• Allograft rejection of ISHLT grade ≥3A occurring late after heart transplantation—a distinct entity?
  The Journal of Heart and Lung Transplantation, 2003
• Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
  New England Journal of Medicine, 2003
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
  Diabetes Care, 2003
• Comparison of long-term effects between tacrolimus and cyclosporine based immunosuppression after HTx
  The Journal of Heart and Lung Transplantation, 1999